Company / Capital Returned to Shareholders
LEXICON PHARMACEUTICALS, INC. Capital Returned to Shareholders History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$864.0K
FY2024
5-year range
$621.0K / $2.7M
FY2020-FY2024
Trend
-67.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Returned to Shareholders has fluctuated over the past 9 years, ranging from $108,000 in FY2013 to $3M in FY2023.
Based on SEC 10-K filings.
$864,000 in FY2024 with a 10-year CAGR of +11.7%.
Declined from $1M to $864,000 over the past 5 years.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -3.4%
- 10-Year CAGR
- +11.7%
Key checks
Key Insights
- 5-year CAGR of -3.4%, indicating a declining trend.
- In FY2024, capital returned to shareholders decreased 67.7% year-over-year.
- Peak capital returned to shareholders was recorded in FY2023.
- Lowest capital returned to shareholders in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $864.0K | -67.7% |
| FY2023 | $2.7M | +160.7% |
| FY2019 | $1.0M | +65.2% |
| FY2018 | $621.0K | +73.9% |
| FY2017 | $357.0K | -59.8% |
| FY2016 | $887.0K | +1.6% |
| FY2015 | $873.0K | +206.3% |
| FY2014 | $285.0K | +163.9% |
| FY2013 | $108.0K | -27.5% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026